Insider Transactions in Q4 2021 at Re Shape Lifesciences Inc. (RSLS)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 02
2021
|
Thomas Stankovich Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,304
-1.16%
|
$4,304
$1.83 P/Share
|
|
Dec 02
2021
|
Barton P. Bandy President and CEO |
SELL
Open market or private sale
|
Direct |
13,427
-1.55%
|
$13,427
$1.83 P/Share
|
|
Nov 18
2021
|
Thomas Stankovich Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
20,000
+5.13%
|
$40,000
$2.02 P/Share
|
|
Nov 02
2021
|
Thomas Stankovich Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,320
-1.22%
|
$8,640
$2.69 P/Share
|
|
Nov 02
2021
|
Barton P. Bandy President and CEO |
SELL
Open market or private sale
|
Direct |
13,505
-1.54%
|
$27,010
$2.69 P/Share
|
|
Oct 01
2021
|
Barton P. Bandy President and CEO |
SELL
Open market or private sale
|
Direct |
12,565
-1.41%
|
$25,130
$2.77 P/Share
|
|
Oct 01
2021
|
Thomas Stankovich Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,660
-1.02%
|
$7,320
$2.76 P/Share
|